Prime Medicine (NasdaqGM:PRME) FY Conference September 08, 2025 01:05 PM ET Company ParticipantsAllan Reine - CEO & DirectorConference Call ParticipantsTerence Flynn - Equity Research AnalystTerence FlynnOkay, thanks everybody for joining us. I'm Terence Flynn, Morgan Stanley's US biopharma analyst, very pleased to be hosting Prime Medicine this afternoon. From the company, we have Allan Reine, the company's CEO. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.mor ...